SYNLOGIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.83 USD | +3.39% |
|
+4.57% | -52.47% |
| Mar. 21 | Synlogic, Inc. Announces Board Changes | CI |
| Mar. 21 | North American Morning Briefing : Investors -2- | DJ |
Chart calendar Synlogic, Inc.
0fa9062a5bdc361bef49c16555.GV8rjd3vfPQLnCm5T1CT7WgRi3z-gSLFpcCi6shtlU0.YwxM3bSfOMxxyG7UKyXfgiNFxSbL-xKGkIuPn4svzB9RDRq8mawbwnnRSg~3d650276ce6cded8806f3f8645067862
Upcoming events on Synlogic, Inc.
Past events on Synlogic, Inc.
| 2024-03-19 07:00 am | Q4 2023 Earnings Release |
| 2024-01-17 10:00 am | Sidoti & Company LLC Micro Cap Virtual Conference |
| 2023-12-09 02:35 pm | Microbiome Engineering International Conference - Poster Session B |
| 2023-11-16 10:00 am | Sidoti Microcap Virtual Conference |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-10-02 04:30 pm | Chardan Genetic Medicines Conference - Fireside Chat |
| 2023-09-21 09:00 am | Extraordinary Shareholders Meeting |
| 2023-09-13 09:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-10 07:00 am | Q2 2023 Earnings Release |
| 2023-07-10 | SVB Securities Therapeutics Forum |
| 2023-06-15 08:00 am | Annual General Meeting |
| 2023-06-07 02:00 pm | Jefferies Global Healthcare Conference |
| 2023-06-01 06:45 pm | Synthetic Biology Engineering Evolution & Design Conference |
| 2023-06-01 | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 51C |
| 2023-05-31 | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 51B |
| 2023-05-30 07:00 pm | Synthetic Biology Engineering Evolution & Design Conference - Poster Number - 38A |
| 2023-05-11 06:50 am | Q1 2023 Earnings Release |
| 2023-05-10 02:30 pm | Sidoti Micro-Cap Virtual Conference |
| 2023-03-29 06:40 am | Q4 2022 Earnings Release |
| 2023-03-19 10:00 pm | Society for Inherited Metabolic Disorders Meeting - Poster No. - #95 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,22 1,34 65.83% | 0,55 0,53 2.83% | 1,75 1,36 28.52% | 1,18 1,31 -10.06% | 3,37 3,34 1.06% | 0,26 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -54,4 -56,1 2.95% | -60,5 -60,5 0.08% | -60,8 -63,0 3.49% | -67,4 -68,2 1.14% | -55,2 -58,1 5.08% | -29,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,4 -53,5 3.96% | -59,2 -59,2 0.11% | -60,6 -62,8 3.62% | -66,1 -67,5 1.99% | -57,3 -55,8 -2.67% | -26,9 |
|
Net income Million USD | Released Forecast Spread | -51,4 -53,5 3.96% | -59,2 -59,1 -0.12% | -60,6 -62,8 3.53% | -66,1 -67,7 2.24% | -57,3 -54,1 -5.79% | -24,5 |
|
EPS USD | Released Forecast Spread | -25,5 -26,8 4.95% | -24,7 -25,1 1.39% | -16,3 -17,5 6.36% | -13,8 -14,1 1.87% | -8,81 -6,25 -40.88% | -2,52 |
| Announcement Date | 12/03/20 | 25/03/21 | 17/03/22 | 29/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,59 0,18 228.89% | 0,24 0,16 52.5% | 0,15 0,12 26.67% | 0,68 0,09 674.86% | 0,11 0,23 -52.89% | 0,17 0,14 24.51% | 0,04 0,13 -72.29% | 0,39 0,08 399.56% | 2,77 2,74 1.24% | 0,07 | 0,07 | 0,07 | 0,07 |
|
EBIT Million USD | Released Forecast Spread | -15,1 -17,3 12.69% | -15,8 -17,5 9.8% | -16,0 -16,6 3.46% | -18,3 -16,1 -13.77% | -17,3 -18,1 4.32% | -16,2 -17,2 5.54% | -15,7 -20,4 23.34% | -12,6 -22,5 43.81% | -10,6 -13,6 21.73% | -19,3 | -3,31 | -3,30 | -3,30 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,1 -17,5 13.71% | -15,7 -17,4 9.9% | -15,8 -16,6 4.37% | -17,9 -16,1 -11.22% | -16,7 -18,1 7.63% | -15,6 -16,9 7.75% | -15,0 -19,9 24.42% | -12,1 -21,9 44.89% | -14,5 -13,0 -11.43% | -18,8 | -2,75 | -2,70 | -2,70 |
|
Net income Million USD | Released Forecast Spread | -15,1 -17,3 12.6% | -15,7 -17,0 7.75% | -15,8 -16,4 3.66% | -17,9 -16,1 -11% | -16,7 -18,2 8.51% | -15,6 -17,0 7.87% | -15,0 -17,9 16.16% | -12,1 -18,6 35.08% | -14,5 -11,4 -27.26% | -14,0 | -4,48 | -3,45 | -2,60 |
|
EPS USD | Released Forecast Spread | -2,40 -3,93 38.93% | -3,30 -4,20 21.43% | -3,30 -3,49 5.38% | -3,75 -3,49 -7.53% | -3,60 -3,83 5.88% | -3,45 -3,49 1.08% | -3,15 -3,55 11.27% | -2,57 -2,56 -0.59% | -0,97 | -1,50 | -0,43 | -0,34 | -0,26 |
| Announcement Date | 17/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 29/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 19/03/24 | - | - | - | - |
More events
Past sector events for Synlogic, Inc.
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYBX Stock
- Calendar Synlogic, Inc.
